Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial
Billings LK, Andreozzi F, Frederiksen M, et al.
Lancet Diabetes Endocrinol. Pub. online 4 Jun 2025.
Leggi


